Patch testing in children: An Patch testing in children: An experience from Kashmir experience from Kashmir Sir, Allergic contact dermatitis in children is a significant problem worldwide and should be an important diagnostic consideration in children with chronic refractory dermatitis. Allergic contact dermatitis used to be considered a rare problem in children but the prevalence is currently estimated to be between 14.5% and 70%. [1] Patch testing in children differs significantly from that in adults, although it is accepted that the dilution of allergens used should be same in both groups. [2] In our study, all children in the age group of 1-18 years suffering from any persistent, pruritic, eczematous dermatitis including resistant classical atopic dermatitis and atypical atopic dermatitis were included. The study was conducted for a period of 1 year, from August 2013 to July 2014 in the contact dermatitis clinic of the Department of Dermatology, SMHS Hospital, Government Medical College, Srinagar, after obtaining approval of the institute ethics committee. A detailed history was taken followed by a thorough cutaneous examination. Patch test was performed after excluding any contraindications to the procedure.
A twenty-allergen Indian standard battery approved by the Contact and Occupational Dermatoses Forum of India (CODFI) and marketed by Systopics India Pvt. Ltd., was used. Readings were carried out as per the International Contact Dermatitis Research Group guidelines on day 2, 30 minutes after removal of the patches with a second reading on day 4 and again on day 7, if required. [3] A total of 60 patients in the age group of 1-18 years were studied [ Table 1 ] with a mean age of presentation of 9.52 ± 2.13 (mean ± standard deviation) years. The male: female ratio was 1:1.8 and 68.3% of the patients were from urban areas. The most common presentation was pruritic eczematous dermatitis. The most common symptoms were itching and exudation. The sites commonly involved were hands, feet, face, eyelids, neck, legs and arms [ Table 2 ].
A positive patch test was seen in 20 (33%) patients, 14 (70%) girls and 6 (30%) boys. Among these, 15 patients had positive reactions which were determined to be of "definite" or "probable" current clinical relevance. The total number of positive reactions was 44 (average of 2.2 reactions per patient). Eight patients showed a positive reaction to a single allergen and 12 to multiple allergens. Positive patch test reactions increased with age; 26.7% in 1-6 years, 26.9% in 7-12 years and 47.4% in 13-18 years age group [ Table 1 ].
Positive patch test reactions were common with nickel sulfate, cobalt chloride, neomycin sulfate, fragrance mix, potassium dichromate, paraphenylenediamine, balsam of peru, parthenium and black rubber mix [ Table 3 ]. In our study, nickel sulfate was the most common allergen causing 11 (25%) positive reactions with a positive relevance in 63.6% of the patients. Detailed questioning revealed the common sources to be metals in jewelry, ear piercing, zippers and cell phones. Co-sensitization with metals seems to be a cause for cobalt allergy. Use of topical antibiotics in patients of atopic dermatitis caused reactions to neomycin sulfate.
Exposure to cosmetics and perfumes resulted in positive reactions to fragrance mix and peru balsam. Use of leather footwear and construction activity at/near homes seemed to trigger hypersensitivity to potassium A patch test positivity rate of 33% in our study is comparable to previous studies done on adult subjects in Kashmir which showed a prevalence of 38.8%; quite low, however, when compared to other Indian studies. The lower prevalence may be because of probable exposure to different allergens in our population, not included in the Indian standard series. [4] [5] [6] Our study demonstrates that the commercially available patch test devices are safe in the pediatric population and patch testing can be performed in children older than 12 years in the same manner as in adults. However, in children younger than 6 years of age, patch test is usually reserved for cases with a high likelihood of contact hypersensitivity. After the culpable allergens are identified by patch testing, and if the patient can take steps to evade them, a significant improvement in the dermatitis is usually seen. [7] This study demonstrates a need for additional multi-center, prospective studies incorporating a larger sample size. The low prevalence of contact Dermatophytoma: An under-Dermatophytoma: An underrecognized condition recognized condition
Sir, Dermatophytoma appears as linear, single or multiple white or yellow bands on the nail plate and can be easily diagnosed from external appearances. Biofilm development is proposed for the pathogenesis of this infection that is composed of a fungal ball formed by abundant fungal filaments and large spores. [1] [2] [3] As the fungal mass firmly attaches to the nail plate and produces an extracellular polysaccharide, it leads to decreased antifungal penetration making the condition resistant to standard antifungal therapy. [4, 5] Oral antifungal treatment alone is not enough to treat this condition [6] and either chemical or physical debridement is essential to eliminate dermatophytoma. [7] General practitioners and non-dermatologist specialists are usually the first to treat fungal nail infections but their knowledge of dermatophytoma treatment is probably limited. As a first step in developing the clinical practice standard for the treatment of dermatophytoma, we evaluated knowledge about this condition in general practitioners and non-dermatologist specialists at the annual meeting of the Dermatological Society of Thailand in February 2013. We used questionnaires and a short answer pretest, composed of a typical picture of toenail dermatophytoma followed by three questions: What is the diagnosis? How would you assess this patient? What is the appropriate management? [ Figure 1 ]. The questionnaire also asked about the respondent's level of confidence in the management of dermatologic patients. The study was approved by the hospital ethics committee.
This test was taken by 82 (96.5% of those registered) physicians who voluntarily returned their answer sheets. Sixty-six (80.5%) participants were general practitioners while the rest were non-dermatologist specialists. Among the physicians, 59 (72%) were
